Bristol could rival Golden Triangle for biotech innovation, says Unit DX director

15 November 2018

Novo Nordisk’s (NOV: N) decision to spend up to $800 million buying the synthetic glucose specialist Ziylo has thrown a spotlight on Unit DX, a biotech incubator based in Bristol, UK.

Ziylo chief executive Harry Destecroix co-founded the startup after struggling to find adequate laboratory space in the city.

After just one year, the facility had reached 60% capacity, hosting 23 hi-tech firms focusing on a range of technologies, including peptide specialist Zentraxa and cell and gene therapy company Cytoseek.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK